Deep motif deconvolution of HLA-II peptidomes for robust class II epitope predictions
J. Racle, J. Michaux, G. A. Rockinger, M. Arnaud, S. Bobisse, C. Chong, P. Guillaume, G. Coukos, A. Harari, C. Jandus, M. Bassani-Sternberg, D. Gfeller
Abstract
CD4 T cells are key for priming and regulating immune recognition of infected and cancer cells, but predictions of class II epitopes have limited accuracy. We combined unbiased Mass Spectrometry-based HLA-II peptidomics with a novel motif deconvolution algorithm to profile and analyze a total of 99265 unique HLA-II ligands. Our work demonstrates substantial improvement in the definition of HLA-II binding motifs and enhanced accuracy in class II epitope predictions.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Improved prediction of MHC II antigen presentation throughintegration and motif deconvolution of mass spectrometryMHC eluted ligand data
Birkir Reynisson, Carolina Barra, … Morten Nielsen·Journal of Proteome ResearchPeer-reviewed·Apr 18, 2020
- Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes
J. Racle, P. Guillaume, … D. Gfeller·bioRxiv·Jun 26, 2022
- HLA-class II specificity assessed by high-density peptide microarray interactions
T. Osterbye, M. Nielsen, … S. Buus·bioRxiv·Feb 28, 2020
- Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome
S. Kaabinejadian, C. Barra, … M. Nielsen·bioRxiv·Nov 23, 2021
- Deciphering the landscape of phosphorylated HLA-II ligands
M. Solleder, J. Racle, … D. Gfeller·bioRxiv·Jun 29, 2021
- Predicting MHC-I ligands across alleles and species: How far can we go?
Daniel M. Tadros, Julien Racle, David Gfeller·Genome MedicinePeer-reviewed·Mar 20, 2025